Please use this identifier to cite or link to this item:
http://hdl.handle.net/123456789/47739Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Lanese, Nicoletta | - |
| dc.date.accessioned | 2024-10-19T03:33:02Z | - |
| dc.date.available | 2024-10-19T03:33:02Z | - |
| dc.date.issued | 2024-04-11 | - |
| dc.identifier.uri | http://hdl.handle.net/123456789/47739 | - |
| dc.description | This article discusses groundbreaking research that identifies specific antibodies capable of targeting the elusive 'dark side' of the influenza virus. Unlike traditional antibodies that focus on well-known viral components, these antibodies interact with less accessible regions of the virus, potentially paving the way for more effective vaccines and treatments. (page 20) | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | How It Works | en_US |
| dc.subject | Influenza | en_US |
| dc.subject | Immune system | en_US |
| dc.title | Scientists reveal antibodies that target the 'dark side' of flu | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | Magazine Index | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Scientists reveal antibodies that target the 'dark side' of flu.pdf | Scientists reveal antibodies that target the 'dark side' of flu | 10.47 MB | Adobe PDF | View/Open |
Items in QC LIBROS are protected by copyright, with all rights reserved, unless otherwise indicated.